Evidence map›Paper›PMID 25784580›Full record

ArticleJournal of oncology practice2015

Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study.

Thomas W LeBlanc, Jonathan D O'Donnell, Megan Crowley-Matoka, Michael W Rabow, Cardinale B Smith, Douglas B White, Greer A Tiver, Robert M Arnold, Yael Schenker

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of oncology practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 3 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 3 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Perceptions of palliative care among patients with advanced cancer and their caregivers.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016
    Trial
  8. Article
  9. Review
  10. Review
  11. Caregiver experiences managing information prior to hematopoietic stem cell transplantation and after transition to home: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  12. Observational
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. A multicentre survey on the perception of palliative care among health professionals working in haematology.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Thomas W LeBlancDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA thomas.leblanc@duke.edu.
Jonathan D O'DonnellDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
Megan Crowley-MatokaDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
Michael W RabowDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
Cardinale B SmithDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
Douglas B WhiteDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
Greer A TiverDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
Robert M ArnoldDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
Yael SchenkerDuke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA.
University of Pittsburgh · USIcahn School of Medicine at Mount Sinai · USUniversity of California, San Francisco · USDuke University · USNorthwestern University · US

Funding

University of Pittsburgh Clinical and Translational Science InstitutionKL2TR000146 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$8.7M
NCATS NIH HHS KL2 TR000146NCATS NIH HHS KL2TR000146
6 · The paper itself

Abstract

purposePatients with hematologic malignancies are less likely to receive specialist palliative care services than patients with solid tumors. Reasons for this difference are poorly understood.

methodsThis was a multisite, mixed-methods study to understand and contrast perceptions of palliative care among hematologic and solid tumor oncologists using surveys assessing referral practices and in-depth semistructured interviews exploring views of palliative care. We compared referral patterns using standard statistical methods. We analyzed qualitative interview data using constant comparative methods to explore reasons for observed differences.

resultsAmong 66 interviewees, 23 oncologists cared exclusively for patients with hematologic malignancies; 43 treated only patients with solid tumors. Seven (30%) of 23 hematologic oncologists reported never referring to palliative care; all solid tumor oncologists had previously referred. In qualitative analyses, most hematologic oncologists viewed palliative care as end-of-life care, whereas most solid tumor oncologists viewed palliative care as a subspecialty that could assist with complex patient cases. Solid tumor oncologists emphasized practical barriers to palliative care referral, such as appointment availability and reimbursement issues. Hematologic oncologists emphasized philosophic concerns about palliative care referrals, including different treatment goals, responsiveness to chemotherapy, and preference for controlling even palliative aspects of patient care.

conclusionMost hematologic oncologists view palliative care as end-of-life care, whereas solid tumor oncologists more often view palliative care as a subspecialty for comanaging patients with complex cases. Efforts to integrate palliative care into hematologic malignancy practices will require solutions that address unique barriers to palliative care referral experienced by hematologic malignancy specialists.

Indexed as

Hematologic NeoplasmsMedical OncologyPalliative CareSpecializationAdultAttitude of Health PersonnelFemaleHumansMaleMiddle AgedPerceptionPractice Patterns, Physicians'Surveys and Questionnaires

Identifiers

PMID25784580
PMCPMC4893821
OpenAlexW2034323666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.